Global Surgical Site Infection Control Market Growth (Status and Outlook) 2023-2029
LPI (LP Information)' newest research report, the “Surgical Site Infection Control Industry Forecast” looks at past sales and reviews total world Surgical Site Infection Control sales in 2022, providing a comprehensive analysis by region and market sector of projected Surgical Site Infection Control sales for 2023 through 2029. With Surgical Site Infection Control sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Surgical Site Infection Control industry.
This Insight Report provides a comprehensive analysis of the global Surgical Site Infection Control landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Surgical Site Infection Control portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Surgical Site Infection Control market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Surgical Site Infection Control and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Surgical Site Infection Control.
The global Surgical Site Infection Control market size is projected to grow from US$ 3147.5 million in 2022 to US$ 4484.3 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.
United States market for Surgical Site Infection Control is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Surgical Site Infection Control is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Surgical Site Infection Control is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Surgical Site Infection Control players cover BD, 3M, Biomerieux, Kimberly-Clark, Getinge Group, B. Braun, Johnson & Johnson, Belimed and Lac-Mac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Surgical Site Infection Control market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Manual Reprocessors Solution
Skin Preparation Solution
Disinfectants
Surgical Scrubs
Surgical Clippers
Surgical Gloves
Textiles
Others
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
3M
Biomerieux
Kimberly-Clark
Getinge Group
B. Braun
Johnson & Johnson
Belimed
Lac-Mac
Sotera Health
Ansell
STERIS Corporation
Pacon Manufacturing
Please note: The report will take approximately 2 business days to prepare and deliver.